Figure 2.
Progression free survival of sunitinib treatment. The median progression free survival (PFS) with sunitinib is shown by Kaplan-Meier estimate (median 249 days).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.